PDB47 Understanding the Implications of Incorporating the UKPDS Glycaemic Legacy Effect Into Evaluating the Cost-Effectiveness of Type 2 Diabetes Therapies

Autor:	Phil McEwan, Klas Bergenheim, M. Prettyjohns
Rok vydání:	2011
Předmět:	medicine.medical_specialty endocrine system diseases Cost effectiveness business.industry Health Policy Public Health Environmental and Occupational Health nutritional and metabolic diseases Type 2 diabetes medicine.disease Endocrinology Internal medicine medicine business Intensive care medicine
Zdroj:	Value in Health. 14(7)
ISSN:	1098-3015
DOI:	10.1016/j.jval.2011.08.1350
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e41e8f3165a7f93ef003d5c5c6606c6d Zobrazit plný text záznamu Full Text from ScienceDirect